Related by context. All words. (Click for frequent words.) 60 NSTE ACS 60 Carotid Revascularization Endarterectomy vs. 59 urolithiasis 59 recurrent glioblastoma multiforme 59 NATRECOR ® 59 multicentre study 59 patientswith 58 Phase IIIb study 58 gynaecologic 58 relapsed MM 57 nucleoside naive 57 Plaquenil 57 patients undergoing CABG 57 transrectal ultrasound guided 57 prospective randomized multicenter 57 undergoing peritoneal dialysis 57 chest radiographs 57 oropharyngeal candidiasis OPC 56 prospective nonrandomized 56 arteriography 56 multicenter randomized controlled 56 phase IIIb 56 multicentre prospective 56 LHRH receptor positive 56 CTEPH 56 Heavy menstrual bleeding 56 epididymitis 56 Coronary Artery Bypass Graft 56 coexisting illnesses 56 cutaneous melanoma 56 renal tumors 55 BPS IC 55 NMIBC 55 prospectively randomized 55 retrospective cohort study 55 chronic periodontitis 55 Chronic Heart Failure 55 treating uterine fibroids 55 relapsing remitting MS RRMS 55 nonvertebral fractures 55 HIV HCV coinfected 55 hemodialysis patients 55 Chlamydia trachomatis infection 55 atrioventricular block 55 histologically confirmed 55 COPD exacerbation 55 leiomyomas 55 observational cohort study 55 retrospective cohort 55 peripartum 55 video assisted thoracoscopic 55 femoral neck fracture 54 Randomized controlled 54 underwent CABG 54 undergone radical prostatectomy 54 chronic prostatitis 54 Oropharyngeal Candidiasis 54 gastroesophageal reflux GERD 54 antiretroviral naïve 54 observational cohort 54 null responder 54 symptomatic BPH 54 histologically proven 54 randomized multicenter 54 perioperatively 54 ritonavir boosted 54 receiving highly emetogenic 54 oesophageal 54 de novo AML 54 nulliparous women 54 multicenter randomized placebo controlled 54 subtrochanteric 54 prospective multicentre 54 prostate cancer PCa 54 abnormal pap tests 54 nondiabetic patients 54 Nonsurgical 54 esophagectomy 54 Thrombolysis 54 Juvenile Idiopathic Arthritis 53 osteopenic 53 tirofiban 53 colorectal adenoma 53 RE LY ® 53 multicenter prospective 53 prospective observational 53 multicentre 53 clinically evaluable 53 recurrent venous thromboembolism 53 recurrent genital herpes 53 Dr. Kandzari 53 prulifloxacin 53 randomized multicenter trial 53 cervicitis 53 rheumatic arthritis 53 microbiologically evaluable 53 CHAMPION PCI 53 Behçet disease 53 Enhanced External Counterpulsation 53 inhaled bronchodilators 53 nonrandomized 53 liver transplant recipients 53 CYPHER Stent 53 prospective randomized controlled 53 certolizumab 53 systemic JIA 53 underwent resection 53 angiographically 53 visceral metastases 53 HIV coinfected 53 prospective multicenter 53 melphalan prednisone 53 pretransplant 53 cirrhotic patients 53 GH deficiency 53 ischemic cardiomyopathy 53 multicentre randomized 52 NSABP B 52 genitourinary medicine 52 immunocompetent 52 ILLUSTRATE 52 undergoing coronary angiography 52 trials RCTs 52 multicenter Phase II 52 CLINICAL STUDIES 52 operable breast cancer 52 vertebral fracture 52 symptomatic fibroids 52 mCRPC 52 nonmetastatic prostate cancer 52 colon rectal 52 fragility fracture 52 acute respiratory tract infection 52 Buerger Disease 52 treatment naive genotype 52 ultrasonographic examination 52 everolimus eluting stents 52 Pneumocystis carinii pneumonia 52 metastatic malignant melanoma 52 secondary amenorrhea 52 Subgroup analyzes 52 carotid stenosis 52 chronic noncancer pain 52 VLBW infants 52 thromboembolic complications 52 prognostic variables 52 onset AF 52 paroxysmal AF 52 null responder HCV 52 abnormal cytology 52 chemoradiotherapy 52 hypertension diabetes mellitus 52 LV dysfunction 52 morphometric vertebral fractures 51 idiopathic scoliosis 51 phase IIb study 51 KRAS mutations occur 51 label multicenter 51 RSD# oral 51 occult HBV 51 treatmentof 51 MEND CABG 51 Oesophageal 51 BR.# 51 developmental dysplasia 51 hemodynamically significant 51 nephrolithiasis 51 hydroxyurea therapy 51 retrospectively reviewed 51 Di Bisceglie 51 prospectively enrolled 51 completely resected 51 recurrent urinary tract infection 51 % CI #.#-#.# [008] 51 stage IIIb IV 51 longitudinal cohort study 51 retrospectively analyzed 51 blinded randomized controlled 51 chlamydial infections 51 placebo controlled clinical 51 T1c 51 prospective randomized 51 Postmenopausal 51 prospectively evaluated 51 Y Gastric Bypass 51 commonest cause 51 EchoCRT 51 psychiatric outpatients 51 carotid plaques 51 Inpatients 51 HBeAg negative 51 microscopic colitis 51 underwent liver transplantation 51 Multicenter 51 achieved sustained virological 51 URTI 51 Feasibility Trial 51 blind multicenter 51 non squamous histology 51 atopic asthma 51 preserved LVEF 51 Surgical Treatment 51 Peripheral Arterial 51 radical prostatectomy RP 51 Systemic Lupus Erythematosus SLE 51 prostate carcinoma 51 operable pancreatic cancer 51 multicenter clinical 51 using lactulose concomitantly 51 dyslipidaemia 51 bacterial prostatitis 50 hepatitis C genotype 50 acid suppressive medications 50 hepatectomy 50 surgical prophylaxis 50 Opportunistic infections 50 Phase III randomized 50 prospective multicenter randomized 50 prostate cancer CaP 50 #-# Full Text 50 tinea capitis 50 Digital Mammographic Imaging 50 blinded randomized placebo controlled 50 HYVET 50 ABSSSI 50 radical cystectomy 50 beta blocker therapy 50 nephron sparing surgery 50 perioperative complications 50 genotypic resistance 50 immuno compromised individuals 50 multicenter randomized 50 TKAs 50 Patrick Serruys 50 undergoing radical prostatectomy 50 deep sternal wound 50 Phase Ib IIa clinical 50 paclitaxel eluting stents 50 multicenter trials 50 prospective observational cohort 50 HIV seropositive 50 stage IIIB 50 Protease inhibitor 50 hepatic resection 50 placebo controlled Phase III 50 mammograms pap tests 50 fragility fractures 50 locoregional recurrence 50 retrospective observational study 50 MD FAAD associate professor 50 ECASS 50 ascending dose 50 DAPT 50 foot ulcers DFU 50 hyperlipidemia hypertension 50 onset atrial fibrillation 50 cryptogenic stroke 50 TMC# C# 50 atherothrombotic disease 50 gastroplasty 50 ABSORB trial 50 Gonal f 50 pediatrics psychiatry 50 conducted retrospective cohort 50 dose regimens 50 HCV SPRINT 50 systolic dysfunction 50 precancerous cervical 50 Stage IIIb 50 dose escalation phase 50 postoperative complication 50 Phase IIIb clinical 50 ascending dose study 50 BARI 2D 50 stage IIIb 50 refractory CLL 50 % CI #.#-#.# [003] 50 lamivudine monotherapy 50 randomized controlled 50 multicenter randomized clinical 50 Adjustable Gastric Band 50 enfermedad 50 Edge STudy 50 TAXUS Express Stent 50 antiretroviral naive 50 dosage regimens 50 diabetic polyneuropathy 50 randomized #:#:# 50 Methicillin resistant S. aureus 49 weekly subcutaneous injections 49 ug dose 49 Stress Urinary Incontinence 49 spine BMD 49 squamous histology 49 Douglas Losordo MD 49 chronic Hepatitis B 49 recurrent VTE 49 knee arthroplasty 49 blind randomized controlled 49 bronchopulmonary 49 acetabular fracture 49 substudy 49 elevated ALT 49 metaanalysis 49 % CI #.#-#.# [007] 49 suboptimal adherence 49 fructose intolerance 49 PREVENT IV 49 oral prednisolone 49 Non Alcoholic Fatty 49 inhaled corticosteroid therapy 49 pegylated liposomal doxorubicin 49 TMC# r 49 biochemical relapse 49 advanced neoplasia 49 AIR CF1 49 pegylated interferon alfa 2b 49 dose dose escalation 49 SIADH 49 root caries 49 IPAH 49 olanzapine quetiapine 49 Acute Decompensated Heart Failure 49 tipranavir r 49 Thromboembolic 49 coronary angiograms 49 radical retropubic prostatectomy 49 prostate cancer CRPC 49 Hypertensive 49 pheochromocytoma 49 randomized Phase IIb 49 SCIg 49 Urinary tract infection 49 NSTEMI 49 thyroidectomy 49 metastatic RCC 49 Basal Cell 49 EINSTEIN DVT 49 elevated troponin 49 postoperative chemotherapy 49 Commonly prescribed 49 coronary revascularization 49 NaF 49 SORT OUT III 49 TEAEs 49 coinfected patients 49 Amgen Neulasta ® 49 clinico pathological 49 MADIT II 49 PPCM 49 ADHF 49 hematopoietic cancers 49 placebo controlled dose escalation 49 methotrexate monotherapy 49 ACCOMPLISH 49 DIAGNOSED 49 multicenter 49 unexplained vaginal bleeding 49 opioid dependent 49 chlamydial infection 49 chest radiograph 49 induced hepatotoxicity 49 undetectable HBV DNA 49 nonadherent 49 Delayed Graft Function 49 RE LY trial 49 Current Controlled Trials 49 randomized controlled clinical 49 previously untreated follicular 49 lacunar 48 AIR2 Trial 48 ConclusionThis 48 Constipation IBS C 48 tumor histology 48 symptomatic VTE 48 hormonally responsive 48 cervical uterine 48 endocrinology gastroenterology 48 hsCRP levels 48 plasma pharmacokinetics 48 obese postmenopausal 48 PARTNER Trial 48 genital ulcer 48 randomizing patients 48 nonoperative treatment 48 REVIVE Diabetes 48 transmitted infections 48 TMJ dysfunction 48 randomized controlled trials RCTs 48 limiting generalizability 48 TREATMENT 48 HBsAg positive 48 Phototherapy 48 MACCE 48 undergoing bariatric surgery 48 GISSI HF 48 advanced adenomas 48 pneumocystis carinii pneumonia 48 prostate testicular 48 psychiatric comorbidities 48 metastatic HRPC 48 lipid lowering therapy 48 corticosteroid induced 48 Primary endpoints 48 mcg BID 48 debulking surgery 48 PFO migraine 48 #mg QD [002] 48 Subtypes 48 Laparoscopic Adjustable Gastric Banding 48 urine dipstick 48 initiating antiretroviral therapy 48 subgroup analyzes 48 meta regression 48 antenatal corticosteroids 48 postoperative mortality 48 extracapsular extension 48 risperidone olanzapine 48 TAXUS VI 48 comorbid depression 48 P aeruginosa 48 double blinded randomized 48 breast carcinoma 48 intravenous diuretics 48 Chlamydia screening 48 FDA defined valvulopathy 48 relapsed myeloma 48 efavirenz EFV 48 pharmacokinetics PK 48 bacterial gastroenteritis 48 NIDDM 48 Intervention Trial 48 diabetic hypertensive 48 cystectomy 48 longitudinal observational study 48 IV NSCLC 48 lymphadenectomy 48 fibroids endometriosis 48 erectile dysfunction impotence 48 HEPATITIS C 48 multicenter placebo controlled 48 Randomized Evaluation 48 BRCA mutation carriers 48 mildly symptomatic 48 Eclampsia 48 confidence interval #.#-#.# 48 neurology ophthalmology 48 nab paclitaxel 48 genital human papillomavirus 48 phase IIb clinical 48 perinatal outcomes 48 related maculopathy 48 neurosciences orthopedics 48 XIENCE V demonstrated 48 laparoscopic Roux en 47 recurrent miscarriage 47 carotid artery narrowing 47 APTIVUS r 47 clinically localized prostate 47 Prostatic 47 postdischarge 47 benign noncancerous 47 neonatal circumcision 47 adjunctive placebo 47 randomized Phase III 47 LEXIVA r 47 Primary Pulmonary Hypertension 47 phase IIa 47 interventional neuroradiology 47 noninferiority 47 mITT population 47 IN VITRO 47 Phase IIIb 47 HBeAg positive 47 adenoma recurrence 47 benign gynecological 47 Cardio vascular 47 cirrhotic 47 PAP smears 47 aged ≥ 47 dose escalation clinical 47 TG MV 47 cetilistat 47 pelvic reconstructive surgery 47 pyrimidine nucleoside analog 47 elevated serum creatinine 47 #mg/m# [001] 47 immunosuppressive regimen 47 undescended testes 47 landmark ATHENA 47 asymptomatic metastatic 47 GBS colonization 47 HER2 positive cancers 47 shingles herpes zoster 47 incomplete revascularization 47 phase IIa clinical 47 mg/m2 dose 47 gadolinium enhanced 47 PSA nadir 47 radical nephrectomy 47 demonstrated antitumor activity 47 atazanavir ritonavir 47 VITAL Trial 47 William Sandborn MD 47 CLBP 47 randomized blinded 47 sedative pentobarbital sodium 47 definite stent thrombosis 47 mg/m2 cohort 47 EVEREST II 47 Osteoporosis Screening 47 EURIDIS 47 MADIT CRT trial 47 uterus womb 47 T2DM 47 Postmenopausal hormone therapy 47 Randomized trials 47 autoimmune thyroiditis 47 recurrent GBM 47 psychiatric inpatients 47 Ascites 47 axillary node dissection 47 Nonalcoholic Fatty Liver Disease 47 Staph aureus infections 47 METHODS 47 Hysterectomies 47 MD MHSc 47 Operative mortality 47 euthyroid 47 placebo controlled clinical trials 47 patients evaluable 47 posttransplant 47 Topical corticosteroids 47 polymicrobial 47 myocardial infarction MI 47 uncircumcised males 47 HNSCC 47 VTE 47 sublingual nitroglycerin 47 orthopaedists 47 Comorbidities 47 randomized clinical 47 CATIE AD 47 Gonadotropin 47 premature ejaculation PE 47 doxorubicin docetaxel 47 mcg linaclotide 47 warfarin therapy 47 mCRC patients 47 sirolimus eluting stents 47 relapsed GBM 47 CAMMS# 47 periprocedural 47 HIV seronegative 47 Tonsillectomy 47 hMG 47 RRMS patients 47 stomatology 47 perinatal transmission 47 MADIT 47 heavily pretreated 47 Uterine Fibroids 47 Phase Ib clinical 47 solifenacin 47 PGD PGS 47 controlled dose escalation 47 nephrology oncology 46 5-fluorouracil/leucovorin 46 liver biopsies 46 total hip arthroplasty 46 colorectal screenings 46 randomized crossover 46 pharmacodynamic effects 46 pooled comparator 46 prospective cohort 46 Anna Taddio 46 undergoing CABG 46 efficacy evaluable 46 morbidly obese adolescents 46 extensive metabolizers 46 double blinded placebo 46 placebo controlled studies 46 onset diabetes mellitus 46 Haemorrhage 46 Multicentre 46 IDH1 mutation 46 oncoplastic 46 aortic atherosclerosis 46 obstetric complications 46 psychiatric comorbidity 46 Scandinavian Cardiac Outcomes 46 Subgroup analysis 46 liver histology 46 CARDIAC 46 HBeAg negative chronic hepatitis 46 serum lipid levels 46 CI #.#-#.# [002] 46 Screening mammograms 46 underwent radical prostatectomy 46 bowel disorders 46 consultant rheumatologist 46 placebo controlled randomized 46 surfactant therapy 46 Barrett esophagus occurs 46 Screening Trial 46 habitual snoring 46 chemoradiation 46 Genito Urinary 46 multicenter randomized double 46 pneumonectomy 46 CIN3 46 subtherapeutic doses 46 IPTp 46 multicenter phase 46 constipation hemorrhoids 46 preoperative chemotherapy 46 multicentre randomized double 46 testicular tumors 46 Genito Urinary Medicine 46 Pulmonologists 46 baseline LDH 46 insulin detemir 46 Vitamin D deficient 46 OSTEOPOROSIS 46 DMARD therapy 46 Multi Ethnic Study 46 subanalysis 46 thrombolytic therapy 46 rectal gonorrhea 46 cardiac cath 46 CCR5 tropic HIV 46 retrospective observational 46 randomized multicentre 46 REYATAZ r arm 46 AIR CF3 46 seropositivity 46 hypertensive disorders 46 carboplatin paclitaxel 46 conjugated equine estrogen 46 HCV genotype 1 46 singleton pregnancies 46 melanocytic nevi 46 HF ACTION 46 nonsignificant difference 46 Trial ASCOT 46 Acute Respiratory Failure 46 attending antenatal clinics 46 enterotoxigenic E. coli ETEC 46 hyperlipemia 46 cardiology pulmonology 46 Penang Adventist 46 urology cardiology 46 irbesartan 46 Associated Diarrhea 46 menstrual disorders 46 HCV infected 46 locoregional 46 Vulvar 46 asymptomatic carriers 46 undergo bariatric surgery 46 J Nutr 46 SYNTAX 46 % CI #.#-#.# [006] 46 HGPIN 46 SCD HeFT 46 Flu Cy 46 ENGAGE AF TIMI 46 renal dietitians 46 exercise induced bronchoconstriction 46 intravascular ultrasonography 46 randomized controlled trial 46 congenital toxoplasmosis 46 T2 lesions 46 Intermittent Preventive Treatment 46 musculo skeletal pain 46 controlled multicenter 46 neoadjuvant 46 receptive anal intercourse 46 ALLEGRO 46 epithelial ovarian cancer 46 pharmacodynamics PD 46 MEND CABG II 46 IM progesterone 46 meticillin resistant Staphylococcus aureus 46 Contraceptive pill 46 irregular menses 46 fetal echocardiogram 46 Intensive Outpatient 46 imatinib therapy 46 distal radial fractures 46 EASE Program 46 subclinical hypothyroidism 46 Margaret Pearle 46 androgen suppression 46 advanced adenoma 45 HIV uninfected 45 LVSD 45 MIST II 45 Spine Patient Outcomes 45 Gruessner 45 umbilical hernias 45 bladder exstrophy 45 anal intraepithelial neoplasia 45 STEP BD 45 hepatobiliary surgery 45 therapies ACTs 45 dose escalation Phase 45 anal vaginal 45 #:#-# [035] 45 VADT 45 phase Ib 45 hip BMD 45 Sexually active 45 Beike stem cell 45 doxorubicin cyclophosphamide 45 Colorectal 45 pediatric nephrologist 45 Henrik Leffers 45 gestational diabetes mellitus 45 hypothalamic amenorrhea 45 Neuroleptic 45 NNRTI resistance 45 Crohn disease colitis 45 Chlamydia gonorrhea 45 MB ChB 45 estimated glomerular filtration 45 RE LY 45 Cardiac Disease 45 HORIZONS AMI trial 45 Pneumocystis pneumonia 45 Edmundowicz 45 #:#-# [031] 45 genotype 1b 45 ovarian hyperstimulation syndrome 45 placebo controlled trials 45 gastric banding procedure 45 AIM HIGH 45 sero positive 45 Hematologist 45 Exclusion criteria 45 ragweed allergic 45 adalimumab 45 Tenofovir DF 45 Rheumatic 45 Neoplasms 45 ovulation induction 45 peginterferon alfa 2a 45 evaluable 45 macroalbuminuria 45 maxillo facial 45 sustained virological response 45 Randomised 45 Urinary Tract Infection 45 lowest tertile 45 elevated LDL cholesterol 45 nonobese 45 myocardial infarctions 45 HPV vaccine protects 45 T1DM 45 placebo controlled 45 e antigen HBeAg 45 CI #.#-#.# [001] 45 nccam.nih.gov 45 XIENCE V PROMUS Stent 45 Chlamydia infections 45 nonpregnant women 45 drank pomegranate juice 45 viral kinetic 45 dose escalation trial 45 micronutrient supplementation 45 ROCKET AF 45 Polycystic Ovary Syndrome 45 Patient Registry 45 Univariate analysis 45 Medicine www.nlm.nih.gov 45 inhaled tobramycin 45 Obstructive Sleep Apnoea 45 physiotherapy podiatry 45 mammograms Pap tests 45 varicocele 45 glycated hemoglobin levels 45 related CMV Retinitis 45 MD PhD MPH 45 seronegative 45 elective cesarean delivery 45 prednisone prednisolone plus 45 inversely associated 45 chancroid 45 kidney transplant recipients 45 Genitourinary Medicine 45 Phenylketonuria PKU 45 hip fracture 45 MAYO CLINIC 45 diarrheal diseases malaria 45 comorbidities 45 CHAMPION PLATFORM 45 locoregional disease 45 Randomised controlled trial 45 molar pregnancy 45 randomized trials 45 pap smear screening 45 anesthesiology radiology 45 pharmacokinetic PK 45 Abram Hoffer 45 TAXUS IV 45 pharmacologic interventions 45 assn.org 45 ≥ 45 blind randomized 45 RhD negative 45 MD D.Sc. 45 relapsed AML 45 label dose escalation 45 HSCT 45 Medtronic Infuse 45 pneumococcal immunization 45 abdominal irradiation 45 periprocedural MI 45 Multiethnic Study 45 confidence interval CI 44 Ursodiol 44 multivariate analyzes 44 5-FU/LV 44 physiatry 44 Dr. Hyon Choi 44 UVB phototherapy 44 Acute Respiratory Infection 44 preeclamptic 44 Interventional Procedures 44 subclinical atherosclerosis 44 Braunwald 44 HIV seroconversion 44 neurodevelopmental impairment 44 COU AA 44 antibody titer 44 Bengt Winblad 44 CR nPR 44 leukemia lymphomas 44 BMD measurements 44 multicenter study 44 coronary calcification 44 SYNTAX trial 44 ipsilateral stroke 44 PROSTATE CANCER 44 evaluable subjects 44 psychiatric morbidity 44 Dysplasia 44 Anti retroviral therapy 44 blinded placebo controlled 44 BREAST 44 normotensive 44 prospective randomized placebo 44 hypertension cardiovascular disease 44 Untreated chlamydia 44 Phase IIa trial 44 Endotracheal 44 lymphocytosis 44 Pharmion Vidaza 44 enzymatically activated within 44 postmenopausal hormone replacement 44 emtricitabine FTC 44 neurologically impaired 44 MD Sc.D. 44 P = .# 44 timepoints 44 Vaginal gel 44 interventional cardiology cardiovascular 44 elevated CRP 44 FERTILITY 44 Wisconsin Sleep Cohort 44 MD FACG 44 receiving VICTRELIS 44 loud snorers 44 glycated hemoglobin HbA1c 44 RECIST criteria 44 urologic surgery 44 virologic failure 44 nonnucleoside reverse transcriptase inhibitors 44 Fda approved 44 MADIT CRT 44 Mayo Clinic gastroenterologist 44 caesarean section births 44 P. aeruginosa infections 44 anal dysplasia 44 mcg doses 44 randomized #:# 44 journal BJOG 44 Chronic Obstructive Pulmonary 44 Abstract P# [002] 44 Colon Emeric 44 Teresa Graedon Ph.D. 44 plastic surgeons dermatologists 44 Mammography Screening 44 elective percutaneous coronary 44 Abdominal Aortic Aneurysm 44 Gynecologic 44 Soy isoflavones 44 Distinguished Hospitals 44 meta analytic review 44 PCa 44 antifungal creams 44 biochemical recurrence 44 intra uterine insemination IUI 44 colorectal neoplasia 44 oral conjugated estrogens 44 logistic regression analysis 44 prenatal postnatal 44 Clinical Antipsychotic Trials 44 Selzentry TM 44 serum GGT 44 hypercholesterolemic 44 Study Raises Questions 44 adjuvant tamoxifen 44 mg BID dose 44 pap smears mammograms 44 composite endpoint 44 lymphoma myeloma 44 genotype 1a 44 nonpsychotic 44 randomized placebo controlled 44 CERVICAL 44 Allogeneic 44 Etminan 44 androgen deprivation 44 WHEL 44 Calcium supplementation 44 Triamcinolone 44 Heart Failure Clinic 44 adenoma 44 anthropometric measures 44 Kruskal Wallis test 44 blind placebo controlled 44 FDG PET scans 44 DLTs 44 testicular germ cell 44 ERISA trumps 44 spontaneous preterm births 44 lymphoproliferative disorder 44 n = 44 femoral neck BMD 44 antiphospholipid antibody 44 obstetric gynecological 44 Stress Incontinence 44 dosing cohorts 44 Cardio Vascular Disease 44 randomized multicenter Phase III 44 Piero Anversa 44 Leukopenia neutropenia 44 Cystic 44 microvascular function 43 PSADT 43 BMI waist circumference 43 non steroidal anti inflammatories 43 Phase III randomized controlled 43 PRECiSE 43 Partial Responses 43 oncology gastroenterology 43 choriocarcinoma 43 nasal carriage 43 Kaplan Meier analysis 43 Multivariate analyzes 43 esophagus colon 43 musculoskeletal radiologist 43 Phase 1b clinical 43 randomized 43 Endocrine Surgery 43 prospectively defined 43 Herng Ching Lin 43 SWOG 43 clinicopathological 43 antibiotic streptomycin 43 Narayana Hrudayalaya Bangalore 43 Human Papillomavirus Quadrivalent Types 43 cutaneous lymphoma 43 cardiologic 43 Multicenter AIDS 43 malaria endemic regions 43 postdoctoral trainee 43 prevalent sexually transmitted 43 knee OA 43 CVD mortality 43 CC genotype 43 seminal vesicle invasion 43 graft dysfunction 43 atopic 43 Guidelines Issued 43 ECG abnormalities 43 Breast Carcinoma 43 unexplained infertility 43 acute leukemias 43 Lipid Clinic 43 recurrent wheeze 43 prospective longitudinal 43 Dr. Surkin 43 licensed acupuncturists 43 hep C. 43 pneumo 43 urogynecology 43 experimental therapeutics